Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Heart MRI may help decide who needs a heart monitor after stroke

NCT ID NCT06047782

Knowledge-focused Sponsor: Centre Hospitalier Universitaire Dijon Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether a special heart MRI can measure scarring in the left atrium, which might lead to atrial fibrillation. Researchers will enroll 100 people who had a stroke with no clear cause and who are already scheduled to get an implantable heart monitor. The goal is to see if the MRI results can predict who will actually develop atrial fibrillation, potentially reducing the need for monitors in some patients.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Cardiac MRI with contrast agent
What this could lead to
If successful, this could help doctors decide which stroke patients need an implantable heart monitor, potentially reducing unnecessary procedures and costs.
What could go wrong
This is a small pilot study with only 100 participants, so results may not apply to everyone. The MRI technique is still experimental and may not reliably predict atrial fibrillation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2024

Expected to finish

Jan 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient who has provided free, written and informed consent * Patient of legal age * Patient with cryptogenic ischemic stroke within 30 days of inclusion, documented by brain imaging (cerebral angioscan or cerebral MRI) * Patients scheduled for implantable loop recorder implantation within 3 months of ischemic stroke in search of silent AF: * cryptogenic ischemic stroke or stroke with probable cardioembolic cause * no history of atrial fibrillation * no long-term anticoagulant therapy * with life expectancy \>12 months Exclusion Criteria: * Person not affiliated to national health insurance * Person under legal protection (curatorship, guardianship) * Person under court order * Pregnant, parturient or breast-feeding * Adult unable to give consent * Patient diagnosed with AF during stroke assessment * Patient with a contraindication to MRI or gadolinium injection: * Severe renal impairment (\<30ml/min Cockroft clearance due to gadolinium injection) * Claustrophobia / contraindication to MRI (metal implant not MRI compatible) * History of hypersensitivity to gadoteric acid or gadolinium-based contrast agents, and to meglumine * Uncontrolled asthma

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cryptogenic ischemic stroke are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

ischemic stroke stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Implantation of an implantable cardiac monitor Stroke

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Chu Dijon Bourgogne

    RECRUITING

    Dijon, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.